Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Pachyonychia Congenita

• Epidermal Growth Factor Receptor Inhibition for Keratinopathies
• Assessment of KM-001 - Safety, Tolerability, and Efficacy in Patients With PPPK1 or PC
• A Study Evaluating the Safety and Pharmacokinetics of QTORIN Rapamycin 3.9% Anhydrous Gel in the Treatment of Adults With Pachyonychia Congenita
• Study Designed to Evaluate Safety and Efficacy of 1% Topical Formulation of KM-001 on Type 1 Punctate Palmoplantar Keratoderma or Pachyonychia Congenita Diseases
• A Multicenter, Phase 3 Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Safety and Efficacy of QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Pachyonychia Congenita
• VALO-2: Study Evaluating the Safety and Efficacy of PTX022 in the Treatment of Adults With Pachyonychia Congenita
• Phase 2/3 Study Evaluating the Safety and Efficacy of PTX-022 in Treatment of Adults With Pachyonychia Congenita
• Effect of Broccoli Sprout Extract on Keratinocyte Differentiation in Normal Skin
• Topical Sirolimus for the Treatment of Pachyonychia Congenita (PC)
• Simvastatin Treatment of Pachyonychia Congenita
• Botulinumtoxin A Treatment in Epidermolysis Bullosa Simplex and Pachyonychia Congenita
• Study of TD101, a Small Interfering RNA (siRNA) Designed for Treatment of Pachyonychia Congenita